Empower Providers to Deliver First-Line Insomnia Therapy
The only FDA-registered Clinical Decision Support (CDS) Software that empowers healthcare organizations to expand providers' capacity to deliver evidence-based, first-line insomnia therapy at scale.
Insomnia is one of the most prevalent and costly sleep disorders. It affects millions of Americans and drives higher healthcare utilization, chronic disease burden, and reduced quality of life. While clinical guidelines recommend cognitive behavioral therapy for insomnia (CBT-I) as the first-line treatment, limited provider capacity, workforce shortages, and fragmented care models make it difficult for healthcare organizations to deliver this evidence-based therapy at scale.
NOCTEM Health's COAST is the only FDA-registered CDS platform for insomnia care, designed specifically to help healthcare organizations modernize sleep care delivery, increase access to first-line therapy, and equip clinicians to deliver consistent, high-quality care across large patient populations.
Key Takeaways
- Expand access to first-line insomnia care. An FDA-registered clinical decision support (CDS) platform helps healthcare organizations deliver guideline-recommended insomnia therapy to more patients without requiring a proportional increase in provider resources.
- Increase provider capacity and efficiency. By automating patient identification, care pathways, and treatment support, CDS software enables clinicians to manage larger patient populations while maintaining high-quality, evidence-based care.
- Standardize evidence-based care delivery. Clinical decision support software promotes consistent application of best practices, helping reduce care variation and improve adherence to insomnia treatment guidelines across the organization.
- Improve patient engagement and outcomes. Digital care pathways support patients between visits, encouraging treatment adherence, tracking progress, and providing actionable insights that help providers make informed clinical decisions.
- Support scalable, data-driven sleep care. An FDA-registered CDS platform equips health systems with the infrastructure to measure outcomes, optimize care delivery, and expand digital insomnia services as patient demand grows.